12:00 AM
Nov 19, 2012
 |  BC Week In Review  |  Clinical News  |  Clinical Status

JRC-LAMP-vax vaccine: Phase I started

Immunomic began an open-label, U.S. Phase I trial to evaluate 2 or 4 mg intramuscular JRC-LAMP-vax vaccine given on days 0, 14, 28 and...

Read the full 98 word article

User Sign in

Trial Subscription

Get a 4-week free trial subscription to BioCentury Week In Review

Article Purchase

$30 USD
More Info >